<code id='D5E055ED62'></code><style id='D5E055ED62'></style>
    • <acronym id='D5E055ED62'></acronym>
      <center id='D5E055ED62'><center id='D5E055ED62'><tfoot id='D5E055ED62'></tfoot></center><abbr id='D5E055ED62'><dir id='D5E055ED62'><tfoot id='D5E055ED62'></tfoot><noframes id='D5E055ED62'>

    • <optgroup id='D5E055ED62'><strike id='D5E055ED62'><sup id='D5E055ED62'></sup></strike><code id='D5E055ED62'></code></optgroup>
        1. <b id='D5E055ED62'><label id='D5E055ED62'><select id='D5E055ED62'><dt id='D5E055ED62'><span id='D5E055ED62'></span></dt></select></label></b><u id='D5E055ED62'></u>
          <i id='D5E055ED62'><strike id='D5E055ED62'><tt id='D5E055ED62'><pre id='D5E055ED62'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:5384
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Novo Nordisk touts Wegovy study, but still struggling with supply
          Novo Nordisk touts Wegovy study, but still struggling with supply

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesThereleaseofNovoNordisk’slatestearningsreportonThursdayprov

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Timeline: How the deadly wildfires took over Maui day by day

          5:04InthisimageobtainedfromtheCountyofMauiinHawaii,showsawildfireinLahaina,onAug.9,2023.Hawaiiwildfi